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Abstract
Introduction: The diagnosis of post-trauma pituitary stalk transection, which is often life-threatening condition, is frequently delayed. 
In medical literature still exist conflicting data concerning distinguishing this pathology with genetic developmental pituitary stalk 
interruption syndrome (PSIS). 
Case presentation: We present a case of patient with post-trauma pituitary stalk transection resulting in combined life-threatening 
pituitary hormone deficiency (CPHD) and typical MRI picture: atrophic not visible stalk and posterior pituitary and hypotrophic 
anterior pituitary with most typical for this disorders hyperintense signal of distal regenerating axon of hypothalamus (pseudo poste-
rior lobe) at median eminence with not visible posterior pituitary. This latter finding is often confused with ectopic posterior lobe in 
genetically determined PSIS. 
Conclusions: MRI image together with medical history of the head trauma and its strict temporal relation with transient diabetes 
insipidus and the occurrence of CPHD signs, as well as the lack of extrapituitary midline defects differentiate posttraumatic pituitary 
stalk transection syndrome (PSTS) from genetic PSIS. In every case of severe traumatic head injury hormonal evaluation and MRI of 
hypothalamic-pituitary axis should be performed.  
Key words: 
combined pituitary hormone deficiency (CPHD), pituitary stalk interruption syndrome (PSIS), post trauma pituitary stalk disruption 
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Streszczenie
Wstęp: Rozpoznanie pourazowego przerwanie szypuły przysadki, będącego stanem zagrożenia życia, jest często opóźnione. W lite-
raturze można znaleźć nieścisłe informacje dotyczące różnicowania tego stanu z genetycznie uwarunkowanym zespołem przerwania 
szypuły przysadki (pituitary stalk interruption syndrome – PSIS).
Opis przypadku: Przedstawiono przypadek pacjentki z pourazowym przerwaniem szypuły przysadki skutkującym wielohormonalną 
niedoczynnością przysadki (combined life-threatening pituitary hormone deficiency – CPHD) i typowym obrazem w rezonansie mag-
netycznym (magnetic resonance imaging – MRI): atroficznymi, niewidocznymi szypułą i płatem tylnym przysadki oraz hipotroficznym 
płatem przednim oraz – najbardziej charakterystycznym dla tego zaburzenia – hiperintensywnym sygnałem dystalnego regenerują-
cego aksonu podwzgórza (pseudo płat tylny) w miejscu wyniosłości pośrodkowej. Ta ostatnia nieprawidłowość bywa często mylona 
z ektopowo położonym płatem tylnym widocznym w przypadku genetycznie uwarunkowanego PSIS. 
Wnioski: Obraz MRI wraz z urazem głowy w wywiadzie pozostającym w związku czasowym z wystąpieniem przejściowej moczówki 
prostej oraz objawami wielohormonalnej niedoczynności przysadki, jak również brak pozaprzysadkowych zaburzeń linii środkowej 
ciała różnicuje pourazowe przerwanie szypuły przysadki (post-traumatic pituitary stalk transection syndrome – PSTS) i genetycznie 
uwarunkowany PSIS. W każdym przypadku ciężkiego urazu głowy należy dokonać oceny hormonalnej funkcji przysadki oraz MRI 
okolicy podwzgórzowo-przysadkowej.  
Słowa kluczowe: 
wielohormonalna niedoczynność przysadki, zespół przerwania szypuły przysadki (PSIS), pourazowe przerwanie szypuły przysadki 
(PSTS), MRI.
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Established facts and novel insights
Established facts
Pituitary stalk interruption syndrome (PSIS) is a  relatively 
frequent cause of combined pituitary hormone insufficiency 
(CPHD) with a  variety of clinical manifestations. There is in-
creasing recognition that it is a genetic developmental malfor-
mation of the hypothalamo-pituitary region, and other midline 
structures, characterised in MRI by the triad of:
• absent or thin (aplastic or hypoplastic) pituitary stalk,
• absent or small (aplastic or hypoplastic) anterior pituitary 
lobe,
• absent or ectopic (undescendent) posterior pituitary lobe on 
the course of downward outgrowth of the neurohypophysis 
to the typical localization behind anterior pituitary lobe.
Novel insights
Post-traumatic pituitary stalk transection syndrome (PSTS) 
is a rare cause of CPHD albeit of usually severe clinical mani-
festation. It is an acquired consequence of head trauma fol-
lowed by regenerating and regressive changes in hypothala-
mo-pituitary region which may mimic genetic PSIS triad in MRI, 
which are not accompanied by other midline defects:
• absent (transected) pituitary stalk which proximal stump is 
either visible as hyperintensive signal of regenerating nerve 
fibers of the hypothalamo-neurophyseal tract at median em-
inence or it is not visible when stalk is cut higher just at the 
median eminence level,
• small (hypothrophic) anterior pituitary lobe,
• absence (ischemic and neurotrophic atrophy) of posterior 
pituitary.
Introduction
Posttraumatic stalk transection syndrome (PSTS) and pitu-
itary stalk interruption syndrome (PSIS) are still often mistaken 
from one another because of similar names of both syndromes 
and their resemblance in clinical manifestation and the MRI im-
age of hypothalamo-pituitary region. However they are caused 
by entirely different processes: hypoplasia or aplasia in PSIS 
whilst regenerative and regressive changes in PSTS. Both 
disorders can manifest as life-threatening combined pituitary 
hormone deficiency (CPHD) and in both lack of pituitary stalk 
and small anterior pituitary can be found on MRI examination. 
Additionally hyperintense signal of distal regenerating axon of 
hypothalamus (pseudo posterior lobe) at median eminence, 
which is typical only for PSTS and often either confused with 
hyperintense bright spot of ectopic posterior pituitary typical for 
PSIS or incorrectly called so [1–5]. 
Moreover, based on historical data coming from research 
performed in the eighties and nineties of XX century some au-
thors still claim that common etiological factor of both of these 
disorders can be breech delivery leading to structural hypoxic-
ischemic changes in hypothalamo-pituitary region of the brain. 
Over the last two decades there is an increasing understand-
ing of the genetical origin of PSIS associated with mutations of 
transcriptional factor genes which are responsible for develop-
mental pathways of pituitary gland and other midline forebrain 
structures [6–12]. Breech presentation does not seem to be 
the cause of PSIS, but can be the cause of PSTS [2–3, 13, 14].
Distinguishing between PSTS and PSIS is becoming more 
important because of the prevalence of PSIS, which is approxi-
mately 1 per 6000 births [6, 8] and increasing amount of pa-
tients with PSTS after severe head traumas resulting from in-
creasing amount of road traffic accidents and sport injures and 
greater survivability of victims. Traumatic brain injury occurrence 
in pediatric population is about 200–235 per 100 000 cases and 
pituitary stalk transection can be found in about 4% of them 
[15, 16]. However, diagnosis of both of these disorders is de-
layed because of the delay of hormonal assessment and MRI 
examination [17–20]. In PSTS it can be also caused by rou-
tinely performed computer tomography for imaging purpose of 
posttraumatic changes in the brain, which does not reveal pa-
thologies of hypothalamo-pituitary region. Post-mortem studies 
confirmed that hypothalamo-pituitary damage is common after 
fatal traumatic brain injury, but MRI changes were confirmed in 
very few cases [15, 21–24]. 
We present typical case of PSTS and literature overview 
concerning important differences between MRI images, extra-
pituitary disorders and clinical manifestation in PSIS and PSTS. 
Awareness of these differences allow early diagnosing and dif-
ferentiating. We also suggest the use of the term pituitary stalk 
transection syndrome (PSTS) for posttraumatic pituitary stalk 
transection and differentiate it with genetic pituitary stalk inter-
ruption syndrome (PSIS).
Case report
We present a case of 7 year and 10 months old girl who 
was admitted to Pediatrics Institute due to severe, symptom-
atic hypoglycemia during an acute episode of gastroenteritis. 
Hypoglycemia was not responsive to i.v. infusion of glucose 
(lowest glycemia value of 25 mg%). A girl was born at 41 weeks 
of uncomplicated gestation by elective cesarean section due 
to breech presentation, with a birth weight of 3600 g and length 
58 cm. Apgar Score was 10 and after birth congenital disloca-
tion of the right hip was diagnosed. Her family history was insig-
nificant. She had no medical history of any serious diseases or 
health problems until the age of 3 years and 10 months when 
she was admitted to Intensive Care Unit because of severe 
head trauma after being hit by a swing. Computed tomography 
of the head revealed basilar skull fracture, cerebral edema, and 
subarachnoid hemorrhage. For few days she was kept in medi-
cally induced coma and treated with desmopressin because 
of transient diabetes insipidus (diabetes insipidus occurred on 
the day of the head trauma and lasted for few days).
After recovery the patient did not undergo any routine 
medical check-ups. On the present admission physical exami-
nation revealed skin pallor, orthostatic hypotension and short 
stature (< 3rd percentile, –3.33 SDS), body weight appropriate 
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for the height and no signs of sexual maturation (thelarche I, 
pubarche I according to the Tanner scale, axillary hair absent).
Results
Based on laboratory studies secondary adrenal insufficien-
cy was confirmed: morning cortisol level was low 44.8 ng/ml 
(N: 50–230), ACTH – 5.3 pg/ml (N: 10–60) and remained low 
in glucagon stimulation test with max. level 55.5 ng/ml. Low 
serum sodium level (135 mmol/l, N: 135–145) was also found. 
Growth hormone deficiency was diagnosed (0.13 ng/ml dur-
ing hypoglycemia and max. 0.49 ng/ml in two stimulation 
tests, N >10 ng/ml) with low IGF1 concentration (27.1 ng/ml, 
N:  59–297) and it was also confirmed by auxological data: 
growth on the 90th percentile on the growth chart respec-
tively to mid-parental height with growth restriction since the 
age of 4  years, bone age delayed by 5 years when com-
pared to chronological age. Secondary hypothyroidism (fT4 – 
6.6  pmol/l, N:  10–25; fT3 – 1.8 pmol/l, N: 3.0–8.1, TSH – 
2.89 uIU/ml, N: 0.3–4.0) was also confirmed. Gonadotropin lev-
els were not checked as patient was in prepubertal age. Pro-
lactin level checked twice was within normal range (197.9 and 
185.0, N: 130–260 uIU/ml), and there were neither clinical nor 
laboratory symptoms of diabetes insipidus (serum osmolality 
288 mOsm/kg H2O, urine osmolality 119 mOsm/kg H2O). MRI 
of the hypothalamo-pituitary region was performed commer-
cially in Medical Diagnostic Centre VOXEL (sagittal and coronal 
plain T1-weighted and T2-weighted and dynamic post-contrast 
T1-weighted, three millimeter section thickness, 1.5 Tesla scan-
ner) and described primarily as a developmental PSIS anomaly 
with absent pituitary stalk, hypoplastic anterior pituitary and ec-
topic posterior pituitary lobe located in the area of fourth ven-
tricle infundibular recess, dorsally from the optic chiasm. Be-
cause of the strict temporal relation between biochemical and 
somatic symptoms and signs of CPHD with the brain damage 
confirmed in CT, MRI of hypothalamo-pituitary region was reas-
sessed and revealed lack of the pituitary stalk with hiperintense 
signal of distal regenerating axon of the hypothalamus (pseudo 
posterior lobe), hypotrophic anterior pituitary and lack of pos-
terior pituitary bright spot (Fig. 1). The introduction of multiple 
hormonal replacement therapy (hydrocortisone, L-thyroxine, 
human recombinant GH) caused resolution of hypotonia and 
hypoglycemia and normalization of the general condition and 
growth of the child (growth velocity 16 cm/year; Fig. 2).
Discussion
Pituitary stalk interruption syndrome and PSTS have dif-
ferent etiology, clinical manifestation, and are associated with 
different dangers for a patient and demand different medical 
procedures. Because of this, it is crucial to make an accu-
rate diagnosis and start treatment without delay. Current data, 
mainly derived from familial cases and patients with specific 
morphological anomalies associated with PSIS support the 
view that PSIS constitutes an antenatal developmental event 
because of genetic aberrations [6, 9–12, 17]. Mutations of mul-
tiple known genes were confirmed in 5% of examined patients 
(e.g. TGIF, SHH, CDON, GPR161, PROKR2, GLI2, LHX4, OTX2, 
SOX3), but also other yet not defined holoprosencephaly-re-
lated genes are responsible for early fetal mal-development of 
midline structures, which results in hypoplasia or aplasia of pi-
tuitary stalk and anterior pituitary gland as well as results in ab-
sence or failure of the neurohypophysis to descend completely 
into sella turcica [6, 17, 25]. In 48% of PSIS cases extra-pituitary 
midline developmental malformations, especially in the central 
nervous system and the craniofacial structures are present 
(e.g. agenesis of corpus callosum, type 1 Chiari malformation, 
white matter heterotopia, upper incisor agenesis, nasal pyri-
form aperture stenosis, cleft lip and/or palate) [3, 6, 17] whilst 
they never occur as PSTS consequence.
Ischemic insult to the pituitary stalk and or mechanical rup-
ture of the pituitary stalk occurring because of trauma during 
breech delivery had been suspected in the past as a causative 
mechanism of PSIS [2, 26–30]. These hypothesis were based 
on the increased incidence of breech delivery in patients with 
PSIS. However, no pathological proof has been found. Patients 
with PSIS do not exhibit damage to other structures sharing 
the same vascular supply. Both these hypothesis also do not 
explain the association of midline anomalies in these patients. 
Moreover, it seems that this relationship is reverse. Namely, as it 
was stated in our patients, decreased hormone secretion results 
Figure 1. MRI: A) sagittal plain; small, hypotrophic anterior 
pituitary; B) coronal plain; hiperintense signal of distal regener-
ating axon of the hypothalamus (pseudo posterior lobe)
A
B
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Figure 2. Growth chart of presented patient (black arrow-head trauma, red arrow-start of hormonal replacement)
Pituitary stalk interruption syndrome and post-trauma pituitary stalk disruption
Zespół przerwania szypuły przysadki i pourazowe przerwanie szypuły przysadki
Pediatr Endocrinol Diabetes Metab 2019
159© Copyright by PTEiDD 2019
in increased incidence of breech presentation which requires 
caesarian section in PSIS patients [3, 5, 6, 28, 31]. In addition to 
that, two thirds of these patients are born with no reported ad-
verse perinatal events, with cephalic delivery in approximately 
50% and caesarian section in 15% of cases, whilst breech de-
livery involves as much as 3% of all births and is present in only 
30% of PSIS patients [31, 32]. Moreover, breech presentation 
and delivery cannot be the cause of extrapituitary defects.
Severe head trauma in perinatal period, but also later in life, 
can lead to pituitary transection and hypopituitarism in these 
cases, because of their etiology, should be included in PSTS 
[2, 13, 14, 31]. In multiple studies with both experimental ani-
mals and patients who had undergone transection of pituitary 
stalk hypophysectomy (therapeutic, traumatic, surgical) of adult 
and children etiology, anatomic changes and MRI picture in pa-
tients after pituitary stalk transection was defined [2, 33–36] .
Surgical transection of the pituitary stalk results in lack of 
pituitary stalk [2, 34–36]. After pituitary stalk transection ante-
rior pituitary gland becomes small and hypotrophic because 
of damage of hypothalamo-hypophyseal portal system and is 
no longer prone to effect of regulatory hormones released by 
hypothalamus. Possible mechanisms of post-traumatic hypo-
pituitarism include not only direct mechanical transection but 
also neuroinflammation and vascular mechanism of injury as 
anatomy of pituitary gland makes it vulnerable to perfusion 
impairment and infarction [37, 38]. The most characteristic for 
pituitary transection is regeneration and regrowth of the nerve 
fibers of the hypothalamo-neurophyseal tract and newly formed 
of pseudo-posterior pituitary lobe tissue at the proximal stump 
of the transected stalk [33–35]. Location of this pseudo-poste-
rior pituitary depends on the level at which the stalk was sec-
tioned [36]. If cut close to the hypothalamus, no ectopic poste-
rior lobe develops. Such location of transected infundibulum is 
logical, as the median eminence (a small swelling on the tuber 
cinereum of the hypothalamus) is attached to the infundibulum 
(pituitary stalk) which ends in the pituitary. As above, MRI in our 
patient shows typical picture of pituitary stalk transection with 
no visible pituitary stalk and present infundibulum stump in the 
median eminence location visible as a hyperintense signal of 
distal axon of hypothalamus. There was hypothrophy of ante-
rior lobe and atrophy (lack) of posterior lobe observed. 
Hiperintense signal of distal axon located in proximal 
stalk stump has been reported in a  series of PSTS children 
described by Fujisawa et al. (1987; 9 patients), Kikuchi et al. 
(1988; 12 patients), Kulkarni et al. (2012; 5 patients), Ergul et al. 
(2017; 1 patient) and was also presented by Ogilvy-Stuart in 
2006 as typical in all newborns with CPHD due to perinatal 
trauma, however this structure have been named in a variety of 
ways e.g. “Pseudo-posterior lobe” [14], “Ectopic posterior pi-
tuitary bright spot”, “Ectopic neurohypophysis”, “Regeneration 
of the distal axon of the hypothalamus, en ectopic, superior 
pituitary gland”, “Blunt ending of infundibulum” or improperly 
just “Ectopic posterior lobe”, as its brightness may mimic this 
of posterior lobe [2, 3, 6, 13, 14, 39]. On the basis of clinical 
observations it is suggested that the bright spot is formed of 
ADH deposits [40].
Location of bright spot (of regenerating neuron in PSTS and 
ectopic posterior pituitary in PSIS), which signal intensity is the 
highest in brain tissue, may differentiate these two conditions. 
In large groups of patients with genetically determined PSIS 
(> 50 patients) characteristic on the T1-weighted MRI imaging 
(T1W1) is not visible posterior pituitary either in normal dorsal 
portion of the sella or in ectopic position (7–21% of patients) or 
ectopic its location (73–100%), visible dependently of the de-
gree of the neurohypophysis mal-descendence between hypo-
thalamus and normal posterior pituitary location: at hypothala-
mus (19% of PSIS patients), at the infundibulum recess (60%) 
or at normal position (5%) [2, 14, 17, 27, 41–44]. 
To a lesser degree these pathologies can be distinguished 
by not visible pituitary stalk, which is typical for PSTS, whilst 
in larger series of 67 children with PSIS not visible pituitary 
stalk was found in only 6% of patients and interrupted or thin 
pituitary stalk was found in 81% and 13% PSTS patients, re-
spectively [17].
The size of anterior pituitary lobe is decreased in most cases 
and it does not allow distinguishing between PSIS and PSTS. In 
PSIS the size depends on mutation’s severity and anterior pitu-
itary hypoplasia can be found in 86% of patients [17]. In PSTS 
this anterior pituitary regression is time – dependent, as it is in 
the post-partum Sheehan syndrome [45]. In Ergul PSTS case, 
anterior pituitary was normal on MRI, but examination was done 
only 6 days after trauma whilst in PSTS cases diagnosed later, 
including our, there were anterior lobe hypothrophy [39]. 
In both PSTS and PSIS patients pseudo-posterior lobe or ec-
topic posterior lobe secret vasopressin (antidiuretic hormone – 
ADH), just as the genuine posterior lobe would. However, tran-
sient diabetes insipidus, which occurred in our patient, may be 
typical for PSTS. As it was described by Reifschneider et al., 
transient diabetes insipidus nearly always occurs early in the 
acute phase after head injury, contrary to the permanent dia-
betes insipidus, which is rare after brain injury in children [46]. 
In Bolado et  al. research diabetes insipidus seems to be an 
indicator of poor prognosis as mortality in this group of patients 
is higher [47].
In both disorders (PSTS and PSIS) can occur severe symp-
toms of adrenal insufficiency like hypoglycemia and hyponatre-
mia [39]. The phenotypical presentation in the neonatal period 
(with the exeptio hypoglycemia and hyponatremia) includes 
micropenis, cryptorchidism and jaundice. Hypoglycemia can 
also be caused by growth hormone deficiency and be accom-
panied with growth retardation worsened by central thyroid in-
sufficiency and central hypogonadism resulting from gonado-
tropin deficiency. Our case in compliance with another current 
reports for PSTS typical is strict temporal relation of hormonal 
signs occurrence with head trauma, which caused pituitary 
stalk transaction, while in PSIS patients it depends upon sever-
ity of the developmental defect and progressive worsening of 
endocrine impairment throughout childhood and adolescence 
[39, 48, 49]. At diagnosis isolated growth hormone deficiency 
is diagnosed in 52% of the PSIS patients while CPHD in 48%, 
and after 12 years follow-up CPHD was confirmed in 83% pa-
tients [17].
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Still recognition both disorders is significantly delayed be-
cause the age at diagnosis depends not only upon the severity 
of clinical manifestation but also on the clinical acuity of the 
caring physician and it is apparent that pertinent hormonal 
symptomatology was not interpreted appropriately, and there-
fore the underlying cause of CPHD escaped detection. Bar et 
al reported that out of 67 patients with PSIS, whose the median 
age at diagnosis was 2.5 years (range: from birth to 16.3 years 
of age). Severe hormonal deficiency (hypoglycemia, jaundice, 
micropenis, and cryptorchidism) was present in 42% of all cas-
es and only 15% of them were diagnosed in infancy period. It 
should be also underline that 70% were primarily evaluated for 
short stature at a median age of 4 years, although decreased 
growth velocity and growth retardation were evident 3 and 
2 years earlier, respectively [1According to some studies the 
diagnosis of CPHD in PSTS children is established between 
the first week to 16 years after head trauma [50–52]. In our 
case the diagnosis of hypopituitarism (GH, ACTH and TSH de-
ficiency) was delayed for 4 years. In PSTS patients the reason 
of delay can be not only clinician’s insufficient awareness of 
endocrine complications of traumatic brain injury but also rou-
tinely performing in such situations only computer tomography 
scan of the head, which does not reveal pathologies of hypo-
thalamo-pituitary region. Post-mortem studies confirmed that 
hypothalamo-pituitary damage is common after fatal traumatic 
brain injury [52, 53], but MRI changes were confirmed in very 
few cases only [55–57]. 
In summary, head trauma followed by biochemical or so-
matic symptoms of pituitary insufficiency together with hyperin-
tense signal of distal axon (infundibulum stump) visible in me-
dian eminence in T1-weighted MRI presentation suggest PSTS. 
For this disorder, lack of extrapituitary midline defects and early 
post-trauma development of transient diabetes insipidus are 
typical. In every case of severe traumatic head injury hormonal 
evaluation and MRI of hypothalamic-pituitary axis should be 
performed.
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